进口九价HPV疫苗获批7年之后,国产九价HPV疫苗终于打破国际垄断,获批上市。中国成为全球第二个具备九价HPV疫苗独立研发与供应能力的国家。市场相关人士表示,当前我国HPV疫苗整体接种率差异化提示市场潜力,男性市场潜在需求将进一步释放,随着万泰生物九价HPV疫苗的上市,将带动更多国产多价HPV疫苗顺势入市,通过市场扩容和政策联动为后续产品创造有利环境,改变市场供应格局。廖木兴/图国产、进口九价...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.